Uk Coronavirus Study
- All
- News
- Videos
-
Omicron Less Likely To Cause Long COVID -19: UK Study
The Omicron variant of coronavirus is less likely to cause long COVID than previous variants, according to the first peer-reviewed study of its kind from the United Kingdom.
-
Only 1 In 4 Covid Patients Feel Fully Recovered After A Year: UK Study
A year after having COVID-19, only around one in four hospitalised patients feel fully recovered, according to a UK study published in The Lancet Respiratory Medicine journal which found that the disease affects women worse than men.
-
Common Colds Can Provide Protection Against Covid: UK Study
High levels of T-cells from common cold coronaviruses can provide protection against COVID-19, an Imperial College London study published on Monday has found, which could inform approaches for second-generation vaccines.
-
Booster Can Boost Effectiveness Against Omicron To 88%, UK Studies Show
A third dose of COVID-19 vaccine can provide up to 88 per cent protection against hospitalisation from infection by the Omicron variant of coronavirus, according to early results from studies conducted in the UK.
-
Mixing Covid Vaccines Is Effective In Study on Pfizer, AstraZeneca
Mixing other vaccines with those from AstraZeneca Plc or Pfizer Inc. offers at least as effective protection against Covid-19 as giving two doses of the same shots, a UK study found.
-
As UK Rollouts Jabs For Children, A Study To Test Mixed Dose Schedules
A British study will look into the immune responses of children to mixed schedules of different COVID-19 vaccines as officials try to determine the best approach to second doses in adolescents given a small risk of heart inflammation.
-
Long Covid Affects Up To 1 In 7 Children Months After Infection: Study
As many as 1 in 7 children may have symptoms linked to the coronavirus months after testing positive for COVID-19, the authors of an English study on long COVID in adolescents said on Wednesday.
-
COVID-19 Has More Blood Clot Threat Than Vaccines, Says UK Study: Report
A coronavirus infection presents a much higher risk of developing a blood clot than the first dose of either the Oxford/AstraZeneca or the Pfizer/BioNTech jab, a large study led by the University of Oxford said on Friday.
-
Protection From Pfizer, AstraZeneca Jabs Wanes Within 6 Months: UK Study
Protection against COVID-19 offered by two doses of the Pfizer/BioNTech and the Oxford/AstraZeneca coronavirus vaccines begins to fade within six months, underscoring the need for booster shots, according to researchers in Britain.
-
Double Vaccinated? You're 3 Times Less Likely To Get COVID-19, Says Study
People who have received both doses of their coronavirus vaccine are three times less likely to get infected with COVID-19, a latest UK study has found.
-
Omicron Less Likely To Cause Long COVID -19: UK Study
The Omicron variant of coronavirus is less likely to cause long COVID than previous variants, according to the first peer-reviewed study of its kind from the United Kingdom.
-
Only 1 In 4 Covid Patients Feel Fully Recovered After A Year: UK Study
A year after having COVID-19, only around one in four hospitalised patients feel fully recovered, according to a UK study published in The Lancet Respiratory Medicine journal which found that the disease affects women worse than men.
-
Common Colds Can Provide Protection Against Covid: UK Study
High levels of T-cells from common cold coronaviruses can provide protection against COVID-19, an Imperial College London study published on Monday has found, which could inform approaches for second-generation vaccines.
-
Booster Can Boost Effectiveness Against Omicron To 88%, UK Studies Show
A third dose of COVID-19 vaccine can provide up to 88 per cent protection against hospitalisation from infection by the Omicron variant of coronavirus, according to early results from studies conducted in the UK.
-
Mixing Covid Vaccines Is Effective In Study on Pfizer, AstraZeneca
Mixing other vaccines with those from AstraZeneca Plc or Pfizer Inc. offers at least as effective protection against Covid-19 as giving two doses of the same shots, a UK study found.
-
As UK Rollouts Jabs For Children, A Study To Test Mixed Dose Schedules
A British study will look into the immune responses of children to mixed schedules of different COVID-19 vaccines as officials try to determine the best approach to second doses in adolescents given a small risk of heart inflammation.
-
Long Covid Affects Up To 1 In 7 Children Months After Infection: Study
As many as 1 in 7 children may have symptoms linked to the coronavirus months after testing positive for COVID-19, the authors of an English study on long COVID in adolescents said on Wednesday.
-
COVID-19 Has More Blood Clot Threat Than Vaccines, Says UK Study: Report
A coronavirus infection presents a much higher risk of developing a blood clot than the first dose of either the Oxford/AstraZeneca or the Pfizer/BioNTech jab, a large study led by the University of Oxford said on Friday.
-
Protection From Pfizer, AstraZeneca Jabs Wanes Within 6 Months: UK Study
Protection against COVID-19 offered by two doses of the Pfizer/BioNTech and the Oxford/AstraZeneca coronavirus vaccines begins to fade within six months, underscoring the need for booster shots, according to researchers in Britain.
-
Double Vaccinated? You're 3 Times Less Likely To Get COVID-19, Says Study
People who have received both doses of their coronavirus vaccine are three times less likely to get infected with COVID-19, a latest UK study has found.
